Skip to content

Precigen PGEN Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

Gilead Sciences logo
Gilead SciencesGILD
Merck & Co. logo
Merck & Co.MRK
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.93B+213%

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's property, plant and equipment at cost?
Precigen (PGEN) reported property, plant and equipment at cost of $37.82M in Q1 2026.
How has Precigen's property, plant and equipment at cost changed year-over-year?
Precigen's property, plant and equipment at cost decreased by 0.1% year-over-year, from $37.85M to $37.82M.
What is the long-term trend for Precigen's property, plant and equipment at cost?
Over 5 years (2020 to 2025), Precigen's property, plant and equipment at cost has grown at a -11.7% compound annual growth rate (CAGR), from $69.88M to $37.58M.